Page last updated: 2024-09-03

c 1311 and Hemolysis

c 1311 has been researched along with Hemolysis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beijnen, JH; Buluran, JN; den Brok, MW; Grieshaber, CK; Harms, R; Harvey, MD; Nuijen, B1
Jóźwiak, Z; Pacholska, M; Szwarocka, A1

Other Studies

2 other study(ies) available for c 1311 and Hemolysis

ArticleYear
Compatibility and stability of the novel anti-cancer agent C1311 in infusion devices and its in vitro biocompatibility.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2005, Volume: 11, Issue:1

    Topics: Aminoacridines; Antineoplastic Agents; Buffers; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Incompatibility; Drug Stability; Hemolysis; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Infusions, Intravenous

2005
The effects of imidazoacridinones, new antineoplastic agents, on the human erythrocyte membrane.
    Biochemistry and molecular biology international, 1997, Volume: 43, Issue:4

    Topics: Aminoacridines; Antineoplastic Agents; Biological Transport; Cytoskeletal Proteins; Electron Spin Resonance Spectroscopy; Erythrocyte Membrane; Hemolysis; Humans; Membrane Fluidity; Protein Conformation; Temperature

1997